Vamagloxistat (sodium)
Vamagloxistat (sodium) is glycolate oxidase inhibitor, used to inhibit hyperoxaluria and kidney stones[1].
Product Specifications
CAS Number
2667602-26-6
UNSPSC
12352005
Target
Glycolate Oxidase
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Smiles
O=C(C1=C(OC2=CC=C(C3=CC=C(C4CC(F)(C4)F)C=C3)C=C2)NN=N1)O[Na]
Molecular Formula
C19H14F2N3NaO3
Molecular Weight
393.32
References & Citations
[1]Maag, et al. Preparation of triazole carboxylic acids and esters as glycolate oxidase inhibitors for the treatment of diseases. World Intellectual Property Organization, WO2020010309 A1. 2020-01-09.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740181-500 1x 500 µL
CD59 (heavy chain of Protectin) (BRA-10G), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680676-100 1x 100 µL
MUC18 / Mucin 18 / CD146 (OJ79c), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680096-500 1x 500 µL
Histone H1 (AE-4), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940257-500 1x 500 µL
Cytokeratin, HMW (AE-3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details